Professional
Added to YB: 2024-07-04
Pitch date: 2024-06-25
ILMN [bullish]
Illumina, Inc.
+23.46%
current return
Author Info
No bio for this author
Company Info
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Market Cap
$18.4B
Pitch Price
$109.24
Price Target
188.00 (+39%)
Dividend
N/A
EV/EBITDA
15.81
P/E
27.05
EV/Sales
4.60
Sector
Life Sciences Tools and Services
Category
special_situation
Illumina, Inc.: Completes Spin Off of Grail to Shareholders
ILMN: $188 PT post Grail spinoff. Core sequencing biz valued at $180, 14.5% Grail stake at $8. Narrow moat from intangible assets & switching costs. Flat 2024 outlook. Long-term growth potential in expanding sequencing applications. Risks: disruptive tech, clinical adoption challenges. New mgmt focusing on core biz after activist pressure.
Read full article (9 min)